Data as of Oct 24
| +0.73 / +6.04%|
The 3 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 28.00, with a high estimate of 28.00 and a low estimate of 27.00. The median estimate represents a +118.41% increase from the last price of 12.82.
The current consensus among 4 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.